Find a Provider

Donald Tsai, MD, PhD

Donald Tsai, MD, PhD Physician

Associate Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Tsai is a Penn Medicine employed physician.

Clinical Specialties

Specialties:

  • Medicine
    • Hematology
    • Medical Oncology

Programs & Services:

  • Cancer
    • Bone Marrow Transplant and Stem Cell Transplant Program
    • Leukemia
    • Lymphoma
    • Multiple Myeloma
  • Hematology-Oncology
    • Classical (Non-Malignant) Hematology Program

Board Certification:

  • Medical Oncology, 2001

Conditions & Treatments:

  • Acute Lymphocytic Leukemia in Adults (ALL)
  • Acute Myeloid Leukemia (AML)
  • Blood Cancer
  • cancer - organ transplant patients
  • Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
  • Chronic Myeloid Leukemia (CML)
  • Hodgkin Lymphoma
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Myeloproliferative Neoplams (MPN)
  • Non-Hodgkin Lymphoma

Clinical Interests

Hematologic Malignancy and Stem Cell Transplantation

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Duke University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania

Memberships

American Society of Clinical Oncology, National American Society of Hematology, National American Society of Transplantation, National

Affiliation

Dr. Tsai is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Research Interests:

Posttransplant Lymphoproliferative Disorder

Selected Publications:

Tsai DE, Luskin MR, Kremer BE, Chung AK, Arnoldi S, Paralkar VR, Nasta SD, Stadtmauer EA, Schuster SJ, Xavier M.: A pilot trial of quantitative EBV PCR in patients undergoing treatment for their malignancy: potential use of EBV PCR in multiple cancer types. Leukemia & Lymphoma : 2015.

Luskin MR, Heil DS, Tan KS, Choi S, Stadtmauer EA, Schuster SJ, Porter DL, Vonderheide RH, Bagg A, Heitjan DF, Tsai DE, Reshef R.: The impact of EBT status on characteristics and outcomes of Posttransplant lymphoproliferative disorder. Am J Transplant : 2015.

Carson KR, Newsome SD, Kim EJ, Wagner-Johnston ND, von Geldern G, Moskowitz CH, Moskowitz AJ, Rook AH, Jalan P, Loren AW, Landsburg D, Coyne T, Tsai D, Raisch DW, Norris LB, Bookstaver PB, Sartor O, Bennett CL.: Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer 120 : 2464-2471,2014.

Ellebrecht CT, Choi EJ, Allman DM, Tsai DE, Wegener WA, Goldenberg DM, Payne AS: Subcutaneous veltuzumab, a humanized anti-CD20 antibody, for treatment of refractory pemphigus vulgaris. JAMA Dermatology 150 : 1331-1335,2014.

Karuturi M, Shah N, Frank D, Fasan O, Reshef R, Ahya VN, Bromberg M, Faust T, Goral S, Schuster SJ, Stadtmauer EA, Tsai DE: Plasmacytic Posttransplant lymphoproliferative disorder: a case series of nine patients. Transplant International 26 : 616-622,2013.

Landsburg DJ, Stadtmauer E, Loren A, Goldstein S, Frey N, Nasta SD, Porter DL, Tsai DE, Perl AE, Hexner EO, Luger S: Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens. American Journal of Hematology 88 : 657-660,2013.

Kremer BE, Reshef R, Misleh JG, Christie JD, Ahya VN, Blumenthal NP, Kotloff RM, Hadjiliadis D, Stadtmauer EA. Schuster SJ, Tsai DE.: Post-Transplant Lymphoproliferative Disorder Following Lung Transplantation: A Review of 35 Cases. Journal of Heart and Lung Transplantation 31 : 296-304,2012.

Tizon R, Frey N, Heitjan DF, Tan KS, Goldsteind SC, Hexner EO, Loren A, Luger SM, Reshef R, Tsai D, Vogl D. Davis J, Vozniak M, Fuchs B, Stadtmauer EA, Porter DL: High dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT. Bone Marrow Transplantation : 2012.

Lunardon L, Tsai KJ, Propert KJ, Fett N, Stanley JR, Werth VP, Tsai DE, Payne AS.: Adjuvant rituximab therapy of pemphigus: a single center experience with 31 patients. Archives of Dermatology : 2012.

Reshef R, Luskin MR, Kamoun M, Vardhanabhuti S, Tomaszewski JE, Stadtmauer EA, Porter DL, Heitjan DF, Tsai DE.: Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients. American Journal of Transplantation 11 : 817-825,2011.

Academic Contact Info

Perelman Center for Advanced Medicine
2 West Pavilion
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 614-0037
Fax: (215) 615-5887
Patient appointments: 800-789-PENN (7366)

Related Links